Literature DB >> 4835464

Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases.

W C Love, A Cashell, M Reynolds, N Callaghan.   

Abstract

The linoleic acid content of serum lipids was measured in 47 patients with multiple sclerosis, 29 patients with other neurological diseases, 35 patients with acute non-neurological illnesses, and 49 healthy control subjects. Reduced linoleic acid content of serum lipids was not specific to multiple sclerosis and occurred in all ill patients with acute non-neurological illness. The fatty-acid pattern of serum lipids in illness resembles that of essential fatty-acid deficiency. It seems that this pattern of reduced linoleic acid content with increased oleic, palmitic, and palmitoleic acid content may be a general phenomenon in ill patients.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4835464      PMCID： PMC1611371          DOI： 10.1136/bmj.3.5922.18

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  28 in total

1.  [Thyroid function in multiple sclerosis].

Authors:  A L VALTNERE
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1959

2.  Concentrations and fatty acid composition of serum lipid fractions following ACTH in rabbits.

Authors:  K Kirkeby; I Bjerkedal
Journal:  Acta Med Scand       Date:  1972-12

3.  Disturbances in serum lipids and in their fatty acid composition following acute myocardial infarction.

Authors:  K Kirkeby
Journal:  Acta Med Scand       Date:  1972-12

4.  Myelin constituents of human central nervous system.

Authors:  J Clausen; I B Hansen
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

5.  Fatty acid composition of serum lipids in men with myocardial infarction.

Authors:  K Kirkeby; P Ingvaldsen; I Bjerkedal
Journal:  Acta Med Scand       Date:  1972-12

6.  Lipids and proteins in multiple sclerosis white matter.

Authors:  B Gerstl; L F Eng; M Tavaststjerna; J K Smith; S L Kruse
Journal:  J Neurochem       Date:  1970-05       Impact factor: 5.372

7.  Serum-thyroxine and thyroxine-binding globulin in seriously ill patients.

Authors:  R F Harvey
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

8.  Plasma lipids in human linoleic acid deficiency.

Authors:  F D Collins; A J Sinclair; J P Royle; D A Coats; A T Maynard; R F Leonard
Journal:  Nutr Metab       Date:  1971       Impact factor: 4.169

9.  Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis.

Authors:  S Gul; A D Smith; R H Thompson; H P Wright; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

10.  Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease.

Authors:  J N Cumings; R C Shortman; T Skrbic
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411
View more
  12 in total

1.  Serial levels of plasma linoleic acid in tetanus.

Authors:  N Callaghan; B Kearney; W C Love
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

2.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Serum fatty acid proportions are altered during the year following acute Epstein-Barr virus infection.

Authors:  L L Williams; D M Doody; L A Horrocks
Journal:  Lipids       Date:  1988-10       Impact factor: 1.880

4.  Relationship between plasma and lymphocyte linoleate in multiple sclerosis.

Authors:  W M Tsang; J Belin; J A Monro; A D Smith; R H Thompson; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-08       Impact factor: 10.154

5.  Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.

Authors:  Midori Nagase; Yorihiro Yamamoto; Yusuke Miyazaki; Hiide Yoshino
Journal:  Redox Rep       Date:  2016-02-25       Impact factor: 4.412

6.  A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.

Authors:  D Bates; N E Cartlidge; J M French; M J Jackson; S Nightingale; D A Shaw; S Smith; E Woo; S A Hawkins; J H Millar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

7.  Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.

Authors:  J Cuypers; H Reddemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

8.  Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation.

Authors:  Takako Miyamae; Manabu Seki; Tomoko Naga; Shinya Uchino; Haruki Asazuma; Takuma Yoshida; Yuki Iizuka; Masako Kikuchi; Tomoyuki Imagawa; Yutaka Natsumeda; Shumpei Yokota; Yorihiro Yamamoto
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

9.  Effect of essential fatty acid deficiency on the fatty acid composition and arachidonic acid levels in rat maxillae and mandibles.

Authors:  S Q Alam; M Henderson; B S Alam
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

10.  Study of plasma and red cell phospholipid fatty acids in extrahepatic cholestatic jaundice.

Authors:  M W Scriven; D F Horrobin; M C Puntis
Journal:  Gut       Date:  1994-07       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.